Afirma Thyroid FNA Analysis (Veracyte)October 19, 2017
In recent years, significant advances in understanding the genetic mechanisms of thyroid cancer have changed the way thyroid nodules are treated clinically. Several molecular targets have been associated with malignancy, including microRNA (miRNA), a noncoding endogenous form of RNA that helps regulate gene expression. Previous investigations have detected the dysregulation of miRNAs in malignant thyroid nodules, identifying the potential role of miRNAs in differentiating benign thyroid nodules from malignant ones. The Afirma Thyroid FNA Analysis is a diagnostic service that includes thyroid-specialized cytopathology and gene expression testing for the analysis of FNA thyroid nodule biopsies. This report examines the published evidence regarding the Afirma Thyroid FNA Analysis.
If you have a Hayes login, click here to view the full report on the Knowledge Center.